AU2002307327A1 - Use of an ampa receptor potentiator for the manufacture of a medicament for the treatment of type 2 diabetes - Google Patents

Use of an ampa receptor potentiator for the manufacture of a medicament for the treatment of type 2 diabetes

Info

Publication number
AU2002307327A1
AU2002307327A1 AU2002307327A AU2002307327A AU2002307327A1 AU 2002307327 A1 AU2002307327 A1 AU 2002307327A1 AU 2002307327 A AU2002307327 A AU 2002307327A AU 2002307327 A AU2002307327 A AU 2002307327A AU 2002307327 A1 AU2002307327 A1 AU 2002307327A1
Authority
AU
Australia
Prior art keywords
diabetes
medicament
manufacture
treatment
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002307327A
Other languages
English (en)
Inventor
Emanuele Sher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU2002307327A1 publication Critical patent/AU2002307327A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AU2002307327A 2001-05-04 2002-04-22 Use of an ampa receptor potentiator for the manufacture of a medicament for the treatment of type 2 diabetes Abandoned AU2002307327A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28889101P 2001-05-04 2001-05-04
US60/288,891 2001-05-04
PCT/US2002/011847 WO2002089848A2 (fr) 2001-05-04 2002-04-22 Methode de traitement du diabete

Publications (1)

Publication Number Publication Date
AU2002307327A1 true AU2002307327A1 (en) 2002-11-18

Family

ID=23109101

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002307327A Abandoned AU2002307327A1 (en) 2001-05-04 2002-04-22 Use of an ampa receptor potentiator for the manufacture of a medicament for the treatment of type 2 diabetes

Country Status (5)

Country Link
EP (1) EP1390072A2 (fr)
JP (1) JP2004530680A (fr)
AU (1) AU2002307327A1 (fr)
CA (1) CA2446161A1 (fr)
WO (1) WO2002089848A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5014334B2 (ja) * 2005-10-06 2012-08-29 イーライ リリー アンド カンパニー Ａｍｐａ受容体増強剤
DE102008047461A1 (de) * 2008-09-17 2010-04-15 Dr.Ing.H.C.F.Porsche Aktiengesellschaft Verbindungseinrichtung zum Verbinden von Verkleidungselementen
PL389364A1 (pl) * 2009-10-23 2011-04-26 Uniwersytet Jagielloński Nowe zastosowanie pochodnych 2-pirolidonu
MX2015017253A (es) * 2013-06-13 2016-04-19 Veroscience Llc Composiciones y metodos para tratar trastornos metabolicos.
HUE058153T2 (hu) * 2017-01-24 2022-07-28 Alphala Co Ltd Amid vegyületek és ezek alkalmazása

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2703051B1 (fr) * 1993-03-26 1995-04-28 Adir Nouvelles pyridothiadiazines, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.
US6030968A (en) * 1996-09-17 2000-02-29 The Regents Of The University Of California Positive AMPA receptor modulation to enhance brain neurotrophic factor expression
GB9702194D0 (en) * 1997-02-04 1997-03-26 Lilly Co Eli Sulphonide derivatives
PE20000943A1 (es) * 1998-07-31 2000-09-28 Lilly Co Eli Derivados de sulfonamida
EP1100497B1 (fr) * 1998-07-31 2004-05-12 Eli Lilly And Company Derives de sulfamide heterocyclyles
CN1240677C (zh) * 1999-04-30 2006-02-08 伊莱利利公司 单氟代烷基衍生物
DE60039631D1 (de) * 1999-12-08 2008-09-04 Lilly Co Eli Cyclopentyl sulfonamid derivaten
AU2001261023A1 (en) * 2000-05-24 2001-12-03 Eli Lilly And Company Use of an ampa receptor potentiator for the treatment of obesity

Also Published As

Publication number Publication date
JP2004530680A (ja) 2004-10-07
WO2002089848A2 (fr) 2002-11-14
CA2446161A1 (fr) 2002-11-14
WO2002089848A3 (fr) 2002-12-12
EP1390072A2 (fr) 2004-02-25

Similar Documents

Publication Publication Date Title
AU2180400A (en) A pharmaceutical combination for the treatment of depression
AU2002258063A1 (en) Medicament applicator
AU2002348332A1 (en) Customized physiological monitor
AU2002342050A1 (en) Anesthesia drug monitor
AU2002321888A1 (en) Medical needle
AU4612300A (en) Preventive or therapeutic drugs for diabetes
AU2002249111A1 (en) Process for the preparation of a medical implant
AU2002247280A1 (en) Ocular drug delivery nebulizer
AU2002338303A1 (en) Therapeutic compositions for the treatment of a respiratory tract disease
AU2002353739A1 (en) Therapeutic compounds
AU2002307327A1 (en) Use of an ampa receptor potentiator for the manufacture of a medicament for the treatment of type 2 diabetes
AU2001240561A1 (en) Novel positive allosteric ampa receptor modulators (paarm), method for the production and use thereof as medicaments
IL162853A0 (en) The use of melagatran for the manufacture of a medicament for the treatment of type 1 diabetes mellitus
AU2002336437A1 (en) Therapeutic uses of complement receptor 2
IL162509A (en) Use of deoxypeganine for the production of a drug for treating clinical depression
AU2003209542A1 (en) Use of s-substituted l-crysteine for the manufacture of a medicament for the treatment of dermatological disorders
AU2002327440A1 (en) Treatment of type i diabetes
AU2003301758A1 (en) Use of pyrimidine derivates for the manifacture of a medicament for the treatment of hyper-proliferative disorders
GB0212790D0 (en) Medicament for the treatment of diabetes
AU2002350895A1 (en) Disease treatment using two related compounds wherein at least one of the compound induces a tachyphylactic response which not affect the other compound
AU3071899A (en) Use of pkc-inhibitors for the manufacture of a medicament for the treatment of asthma
AU2002367305A1 (en) Foot orthosis
AU2003242538A1 (en) Use of 2-oxo-1-pyrrolidone derivatives for the preparation of a drug
AU2002348105A1 (en) Oral dosage forms for improving the bioavailability of therapeutic agents
AU2001261023A1 (en) Use of an ampa receptor potentiator for the treatment of obesity

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase